I-BET151 [Ligand Id: 7518] activity data from GtoPdb and ChEMBL
Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
| ChEMBL ligand: CHEMBL2017291 (GSK1210151A) |
|---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
|
There should be some charts here, you may need to enable JavaScript!
|
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
|
There should be some charts here, you may need to enable JavaScript!
|
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
|
There should be some charts here, you may need to enable JavaScript!
|
|
There should be some charts here, you may need to enable JavaScript!
|
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
|
There should be some charts here, you may need to enable JavaScript!
|
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
| DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
|---|---|---|---|---|---|---|---|---|
| α1B-adrenoceptor/Alpha-1b adrenergic receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL232] [GtoPdb: 23] [UniProtKB: P35368] | ||||||||
| ChEMBL | Selectivity interaction (BET inhibitor selectivity panel (Human antagonist intracellular Ca2+ fluorescence assay)) EUB0000102c ADRA1B | B | 4.4 | pIC50 | >40000 | nM | IC50 | Selectivity Literature for EUbOPEN Chemogenomic Library |
| ATPase family AAA domain containing 2/ATPase family AAA domain-containing protein 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2150837] [GtoPdb: 2719] [UniProtKB: Q6PL18] | ||||||||
| ChEMBL | Binding affinity to biotinylated ATAD2A (981 to 1108 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells by bio-layer interferometry method | B | 5 | pKd | >10000 | nM | Kd | J Med Chem (2015) 58: 4927-4939 [PMID:26080064] |
| β2-adrenoceptor/Beta-2 adrenergic receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL210] [GtoPdb: 29] [UniProtKB: P07550] | ||||||||
| ChEMBL | Selectivity interaction (BET inhibitor selectivity panel (Human antagonist TR-FRET assay)) EUB0000102c ADRB2 | B | 4.5 | pIC50 | >31600 | nM | IC50 | Selectivity Literature for EUbOPEN Chemogenomic Library |
| bromodomain containing 2/Bromodomain-containing protein 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1293289] [GtoPdb: 1944] [UniProtKB: P25440] | ||||||||
| ChEMBL | Binding affinity to biotinylated BRD2 BD2 (349 to 460 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells by bio-layer interferometry method | B | 7.15 | pKd | 70.3 | nM | Kd | J Med Chem (2015) 58: 4927-4939 [PMID:26080064] |
| ChEMBL | Binding affinity to biotinylated BRD2 BD1 (72 to 205 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells by bio-layer interferometry method | B | 7.26 | pKd | 54.8 | nM | Kd | J Med Chem (2015) 58: 4927-4939 [PMID:26080064] |
| ChEMBL | Displacement of FAM-labeled ZBA248 from BRD2 BD2 (349 to 460 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells after 30 mins by fluorescence polarization assay | B | 7.3 | pKi | 49.6 | nM | Ki | J Med Chem (2015) 58: 4927-4939 [PMID:26080064] |
| ChEMBL | Displacement of FAM-labeled ZBA248 from BRD2 BD1 (72 to 205 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells after 30 mins by fluorescence polarization assay | B | 8.05 | pKi | 9 | nM | Ki | J Med Chem (2015) 58: 4927-4939 [PMID:26080064] |
| ChEMBL | Affinity Phenotypic Cellular interaction: (Inhibition of MLL-fusion leukemic K562 cells) EUB0000102c BRD2 | F | 4 | pIC50 | >100000 | nM | IC50 | Affinity Phenotypic Cellular Literature for EUbOPEN Chemogenomic Library |
| ChEMBL | Affinity Phenotypic Cellular interaction: (Inhibition of MLL-fusion leukemic MEG01 cells) EUB0000102c BRD2 | F | 4.6 | pIC50 | 25000 | nM | IC50 | Affinity Phenotypic Cellular Literature for EUbOPEN Chemogenomic Library |
| ChEMBL | Affinity Phenotypic Cellular interaction: (Meso-scale discovery human IL6 assay (cytokine production in LPS stimmulated human WB)) EUB0000102c BRD2 | F | 5.9 | pIC50 | 1260 | nM | IC50 | Affinity Phenotypic Cellular Literature for EUbOPEN Chemogenomic Library |
| ChEMBL | Affinity Phenotypic Cellular interaction: (Meso-scale discovery human IL6 assay (cytokine production in LPS stimulated human WB)) EUB0000102c BRD2 | F | 5.9 | pIC50 | 1260 | nM | IC50 | Affinity Phenotypic Cellular Literature for EUbOPEN Chemogenomic Library |
| ChEMBL | Affinity Phenotypic Cellular interaction: (Inhibition of MLL-fusion leukemic HEL cells) EUB0000102c BRD2 | F | 6 | pIC50 | 1000 | nM | IC50 | Affinity Phenotypic Cellular Literature for EUbOPEN Chemogenomic Library |
| ChEMBL | Affinity Phenotypic Cellular interaction: (Inhibition of MLL-fusion leukemic HL60 cells) EUB0000102c BRD2 | F | 6.05 | pIC50 | 890 | nM | IC50 | Affinity Phenotypic Cellular Literature for EUbOPEN Chemogenomic Library |
| ChEMBL | Binding affinity to human BRD2 assessed as inhibition of Alexa Fluor 488 binding after 60 mins by fluorescence anisotropic analysis | B | 6.3 | pIC50 | 501.19 | nM | IC50 | Bioorg Med Chem Lett (2012) 22: 2968-2972 [PMID:22437115] |
| GtoPdb | - | - | 6.3 | pIC50 | 500 | nM | IC50 | Nature (2011) 478: 529-33 [PMID:21964340] |
| ChEMBL | Selectivity interaction (BET inhibitor selectivity panel (Human FP binding assay)) EUB0000102c BRD2 | B | 6.3 | pIC50 | 500 | nM | IC50 | Selectivity Literature for EUbOPEN Chemogenomic Library |
| ChEMBL | Inhibition of BRD2 (unknown origin) by fluorescence anisotrophy | B | 6.3 | pIC50 | 500 | nM | IC50 | J Med Chem (2015) 58: 1281-1297 [PMID:25559428] |
| ChEMBL | Affinity Biochemical interaction: (FP ligand displacement assays) EUB0000102c BRD2 | B | 6.3 | pIC50 | 500 | nM | IC50 | Affinity Biochemical Literature for EUbOPEN Chemogenomic Library |
| ChEMBL | Displacement of Alexa Fluor 647 labelled I-BET762 from N-terminal His6-tagged human BRD2 BD2 (1 to 473 residues)/BD1 Y113A mutant expressed in Escherichia coli after 1 hr by TR-FRET assay | B | 6.7 | pIC50 | 199.53 | nM | IC50 | J Med Chem (2020) 63: 9020-9044 [PMID:32787145] |
| ChEMBL | Affinity Phenotypic Cellular interaction: (Inhibition of MLL-fusion leukemic RS4:11 cells) EUB0000102c BRD2 | F | 6.72 | pIC50 | 192 | nM | IC50 | Affinity Phenotypic Cellular Literature for EUbOPEN Chemogenomic Library |
| ChEMBL | Affinity Phenotypic Cellular interaction: (Meso-scale discovery human IL6 assay (cytokine production in LPS stimulated PBMC cells)) EUB0000102c BRD2 | F | 6.8 | pIC50 | 160 | nM | IC50 | Affinity Phenotypic Cellular Literature for EUbOPEN Chemogenomic Library |
| ChEMBL | Affinity Phenotypic Cellular interaction: (Inhibition of MLL-fusion leukemic MOLM13 cells) EUB0000102c BRD2 | F | 6.92 | pIC50 | 120 | nM | IC50 | Affinity Phenotypic Cellular Literature for EUbOPEN Chemogenomic Library |
| ChEMBL | Displacement of Alexa Fluor 647 labelled I-BET762 from N-terminal His6-tagged human BRD2 BD1 (1 to 473 residues)/BD2 Y386A mutant expressed in Escherichia coli after 1 hr by TR-FRET assay | B | 7.3 | pIC50 | 50.12 | nM | IC50 | J Med Chem (2020) 63: 9020-9044 [PMID:32787145] |
| ChEMBL | Affinity Phenotypic Cellular interaction: (Inhibition of MLL-fusion leukemic MV4:11 cells) EUB0000102c BRD2 | F | 7.59 | pIC50 | 26 | nM | IC50 | Affinity Phenotypic Cellular Literature for EUbOPEN Chemogenomic Library |
| ChEMBL | Affinity Phenotypic Cellular interaction: (Inhibition of MLL-fusion leukemic NOMO1 cells) EUB0000102c BRD2 | F | 7.82 | pIC50 | 15 | nM | IC50 | Affinity Phenotypic Cellular Literature for EUbOPEN Chemogenomic Library |
| bromodomain containing 3/Bromodomain-containing protein 3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1795186] [GtoPdb: 2725] [UniProtKB: Q15059] | ||||||||
| ChEMBL | Binding affinity to biotinylated BRD3 BD2 (306 to 417 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells by bio-layer interferometry method | B | 7.39 | pKd | 40.5 | nM | Kd | J Med Chem (2015) 58: 4927-4939 [PMID:26080064] |
| ChEMBL | Binding affinity to biotinylated BRD3 BD1 (24 to 144 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells by bio-layer interferometry method | B | 7.53 | pKd | 29.8 | nM | Kd | J Med Chem (2015) 58: 4927-4939 [PMID:26080064] |
| ChEMBL | Selectivity interaction (SPR measurement) EUB0000102c BRD3 | B | 7.7 | pKd | 20 | nM | Kd | Selectivity Literature for EUbOPEN Chemogenomic Library |
| ChEMBL | Displacement of FAM-labeled ZBA248 from BRD3 BD2 (306 to 417 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells after 30 mins by fluorescence polarization assay | B | 7.65 | pKi | 22.3 | nM | Ki | J Med Chem (2015) 58: 4927-4939 [PMID:26080064] |
| ChEMBL | Displacement of FAM-labeled ZBA248 from BRD3 BD1 (24 to 144 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells after 30 mins by fluorescence polarization assay | B | 8.14 | pKi | 7.2 | nM | Ki | J Med Chem (2015) 58: 4927-4939 [PMID:26080064] |
| ChEMBL | Affinity Phenotypic Cellular interaction: (Inhibition of MLL-fusion leukemic K562 cells) EUB0000102c BRD3 | F | 4 | pIC50 | >100000 | nM | IC50 | Affinity Phenotypic Cellular Literature for EUbOPEN Chemogenomic Library |
| ChEMBL | Affinity Phenotypic Cellular interaction: (Inhibition of MLL-fusion leukemic MEG01 cells) EUB0000102c BRD3 | F | 4.6 | pIC50 | 25000 | nM | IC50 | Affinity Phenotypic Cellular Literature for EUbOPEN Chemogenomic Library |
| ChEMBL | Affinity Phenotypic Cellular interaction: (Meso-scale discovery human IL6 assay (cytokine production in LPS stimmulated human WB)) EUB0000102c BRD3 | F | 5.9 | pIC50 | 1260 | nM | IC50 | Affinity Phenotypic Cellular Literature for EUbOPEN Chemogenomic Library |
| ChEMBL | Affinity Phenotypic Cellular interaction: (Meso-scale discovery human IL6 assay (cytokine production in LPS stimulated human WB)) EUB0000102c BRD3 | F | 5.9 | pIC50 | 1260 | nM | IC50 | Affinity Phenotypic Cellular Literature for EUbOPEN Chemogenomic Library |
| ChEMBL | Affinity Phenotypic Cellular interaction: (Inhibition of MLL-fusion leukemic HEL cells) EUB0000102c BRD3 | F | 6 | pIC50 | 1000 | nM | IC50 | Affinity Phenotypic Cellular Literature for EUbOPEN Chemogenomic Library |
| ChEMBL | Affinity Phenotypic Cellular interaction: (Inhibition of MLL-fusion leukemic HL60 cells) EUB0000102c BRD3 | F | 6.05 | pIC50 | 890 | nM | IC50 | Affinity Phenotypic Cellular Literature for EUbOPEN Chemogenomic Library |
| ChEMBL | Binding affinity to BRD3 assessed as inhibition of Alexa Fluor 488 binding after 60 mins by fluorescence anisotropic analysis | B | 6.6 | pIC50 | 251.19 | nM | IC50 | Bioorg Med Chem Lett (2012) 22: 2968-2972 [PMID:22437115] |
| GtoPdb | - | - | 6.6 | pIC50 | 250 | nM | IC50 | Nature (2011) 478: 529-33 [PMID:21964340] |
| ChEMBL | Selectivity interaction (BET inhibitor selectivity panel (Human FP binding assay)) EUB0000102c BRD3 | B | 6.6 | pIC50 | 250 | nM | IC50 | Selectivity Literature for EUbOPEN Chemogenomic Library |
| ChEMBL | Inhibition of BRD3 (unknown origin) by fluorescence anisotrophy | B | 6.6 | pIC50 | 250 | nM | IC50 | J Med Chem (2015) 58: 1281-1297 [PMID:25559428] |
| ChEMBL | Affinity Biochemical interaction: (FP ligand displacement assays) EUB0000102c BRD3 | B | 6.6 | pIC50 | 250 | nM | IC50 | Affinity Biochemical Literature for EUbOPEN Chemogenomic Library |
| ChEMBL | Affinity Phenotypic Cellular interaction: (Inhibition of MLL-fusion leukemic RS4:11 cells) EUB0000102c BRD3 | F | 6.72 | pIC50 | 192 | nM | IC50 | Affinity Phenotypic Cellular Literature for EUbOPEN Chemogenomic Library |
| ChEMBL | Affinity Phenotypic Cellular interaction: (Meso-scale discovery human IL6 assay (cytokine production in LPS stimulated PBMC cells)) EUB0000102c BRD3 | F | 6.8 | pIC50 | 160 | nM | IC50 | Affinity Phenotypic Cellular Literature for EUbOPEN Chemogenomic Library |
| ChEMBL | Affinity Phenotypic Cellular interaction: (Inhibition of MLL-fusion leukemic MOLM13 cells) EUB0000102c BRD3 | F | 6.92 | pIC50 | 120 | nM | IC50 | Affinity Phenotypic Cellular Literature for EUbOPEN Chemogenomic Library |
| ChEMBL | Displacement of Alexa Fluor 647 labelled I-BET762 from N-terminal His6-tagged human BRD3 BD2 (1 to 435 residues)/BD1 Y73A mutant expressed in Escherichia coli after 1 hr by TR-FRET assay | B | 7.1 | pIC50 | 79.43 | nM | IC50 | J Med Chem (2020) 63: 9020-9044 [PMID:32787145] |
| ChEMBL | Displacement of Alexa Fluor 647 labelled I-BET762 from N-terminal His6-tagged human BRD3 BD1 (1 to 435 residues)/BD2 Y348A mutant expressed in Escherichia coli after 1 hr by TR-FRET assay | B | 7.5 | pIC50 | 31.62 | nM | IC50 | J Med Chem (2020) 63: 9020-9044 [PMID:32787145] |
| ChEMBL | Affinity Phenotypic Cellular interaction: (Inhibition of MLL-fusion leukemic MV4:11 cells) EUB0000102c BRD3 | F | 7.59 | pIC50 | 26 | nM | IC50 | Affinity Phenotypic Cellular Literature for EUbOPEN Chemogenomic Library |
| ChEMBL | Affinity Phenotypic Cellular interaction: (Inhibition of MLL-fusion leukemic NOMO1 cells) EUB0000102c BRD3 | F | 7.82 | pIC50 | 15 | nM | IC50 | Affinity Phenotypic Cellular Literature for EUbOPEN Chemogenomic Library |
| bromodomain containing 4/Bromodomain-containing protein 4 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1163125] [GtoPdb: 1945] [UniProtKB: O60885] | ||||||||
| ChEMBL | Binding affinity to biotinylated BRD4 BD2 (333 to 460 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells by bio-layer interferometry method | B | 6.67 | pKd | 215 | nM | Kd | J Med Chem (2015) 58: 4927-4939 [PMID:26080064] |
| ChEMBL | Selectivity interaction (SPR measurement) EUB0000102c BRD4 | B | 7 | pKd | 100 | nM | Kd | Selectivity Literature for EUbOPEN Chemogenomic Library |
| ChEMBL | Binding affinity to biotinylated BRD4 BD1 (44 to 168 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells by bio-layer interferometry method | B | 7.28 | pKd | 52.8 | nM | Kd | J Med Chem (2015) 58: 4927-4939 [PMID:26080064] |
| ChEMBL | Inhibition of Cy5-linked JQ1 probe binding to recombinant human N-terminal TEV-cleavable hexa-histidine tagged BRD4 bromodomain2 after 60 mins by HTRF assay | B | 6.41 | pKi | 385 | nM | Ki | Bioorg Med Chem (2019) 27: 457-469 [PMID:30606676] |
| ChEMBL | Displacement of FAM-labeled ZBA248 from BRD4 BD2 (333 to 460 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells after 30 mins by fluorescence polarization assay | B | 7.13 | pKi | 74.8 | nM | Ki | J Med Chem (2015) 58: 4927-4939 [PMID:26080064] |
| ChEMBL | Inhibition of FAM-labeled ZBA248 binding to recombinant human N-terminal His6-tagged BRD4 bromodomain 2 (333 to 460 residues) expressed in Rosetta2 DE3 cells after 30 mins by Flourescence polarization assay | B | 7.13 | pKi | 74.8 | nM | Ki | J Med Chem (2017) 60: 3887-3901 [PMID:28463487] |
| ChEMBL | Inhibition of tetra-acetylated Histone H4 peptide binding to recombinant human N-terminal TEV-cleavable hexa-histidine tagged BRD4 bromodomain1 after 60 mins by ALPHA screen assay | B | 7.21 | pKi | 61 | nM | Ki | Bioorg Med Chem (2019) 27: 457-469 [PMID:30606676] |
| ChEMBL | Displacement of FAM-labeled ZBA248 from BRD4 BD1 (44 to 168 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells after 30 mins by fluorescence polarization assay | B | 8.05 | pKi | 9 | nM | Ki | J Med Chem (2015) 58: 4927-4939 [PMID:26080064] |
| ChEMBL | Inhibition of FAM-labeled ZBA248 binding to recombinant human N-terminal His6-tagged BRD4 bromodomain 1 (44 to 168 residues) expressed in Rosetta2 DE3 cells after 30 mins by Flourescence polarization assay | B | 8.05 | pKi | 9 | nM | Ki | J Med Chem (2017) 60: 3887-3901 [PMID:28463487] |
| ChEMBL | Affinity Phenotypic Cellular interaction: (Inhibition of MLL-fusion leukemic K562 cells) EUB0000102c BRD4 | F | 4 | pIC50 | >100000 | nM | IC50 | Affinity Phenotypic Cellular Literature for EUbOPEN Chemogenomic Library |
| ChEMBL | Affinity Phenotypic Cellular interaction: (Inhibition of MLL-fusion leukemic MEG01 cells) EUB0000102c BRD4 | F | 4.6 | pIC50 | 25000 | nM | IC50 | Affinity Phenotypic Cellular Literature for EUbOPEN Chemogenomic Library |
| ChEMBL | Affinity Phenotypic Cellular interaction: (Meso-scale discovery human IL6 assay (cytokine production in LPS stimmulated human WB)) EUB0000102c BRD4 | F | 5.9 | pIC50 | 1260 | nM | IC50 | Affinity Phenotypic Cellular Literature for EUbOPEN Chemogenomic Library |
| ChEMBL | Affinity Phenotypic Cellular interaction: (Meso-scale discovery human IL6 assay (cytokine production in LPS stimulated human WB)) EUB0000102c BRD4 | F | 5.9 | pIC50 | 1260 | nM | IC50 | Affinity Phenotypic Cellular Literature for EUbOPEN Chemogenomic Library |
| ChEMBL | Inhibition of BRD4 in human whole blood assessed as reduction in LPS-induced IL-6 secretion preincubated for 30 mins followed by LPS stimulation and measured after 24 hrs by MSD assay | B | 5.9 | pIC50 | 1258.93 | nM | IC50 | J Med Chem (2021) 64: 12200-12227 [PMID:34387088] |
| ChEMBL | Affinity Phenotypic Cellular interaction: (Inhibition of MLL-fusion leukemic HEL cells) EUB0000102c BRD4 | F | 6 | pIC50 | 1000 | nM | IC50 | Affinity Phenotypic Cellular Literature for EUbOPEN Chemogenomic Library |
| ChEMBL | Affinity Phenotypic Cellular interaction: (Inhibition of MLL-fusion leukemic HL60 cells) EUB0000102c BRD4 | F | 6.05 | pIC50 | 890 | nM | IC50 | Affinity Phenotypic Cellular Literature for EUbOPEN Chemogenomic Library |
| ChEMBL | Binding affinity to BRD4 assessed as inhibition of Alexa Fluor 488 binding after 60 mins by fluorescence anisotropic analysis | B | 6.1 | pIC50 | 794.33 | nM | IC50 | Bioorg Med Chem Lett (2012) 22: 2968-2972 [PMID:22437115] |
| GtoPdb | - | - | 6.1 | pIC50 | 790 | nM | IC50 | Nature (2011) 478: 529-33 [PMID:21964340] |
| ChEMBL | Selectivity interaction (BET inhibitor selectivity panel (Human FP binding assay)) EUB0000102c BRD4 | B | 6.1 | pIC50 | 794 | nM | IC50 | Selectivity Literature for EUbOPEN Chemogenomic Library |
| ChEMBL | Inhibition of BRD4 (unknown origin) by fluorescence polarization assay | B | 6.1 | pIC50 | 790 | nM | IC50 | Bioorg Med Chem (2018) 26: 2937-2957 [PMID:29776834] |
| ChEMBL | Binding affinity to human BRD4 1/2 bromodomain by fluorescence anisotropic assay | B | 6.1 | pIC50 | 790 | nM | IC50 | J Med Chem (2013) 56: 3217-3227 [PMID:23517011] |
| ChEMBL | Inhibition of BRD4 (unknown origin) by fluorescence anisotrophy | B | 6.1 | pIC50 | 790 | nM | IC50 | J Med Chem (2015) 58: 1281-1297 [PMID:25559428] |
| ChEMBL | Affinity Biochemical interaction: (FP ligand displacement assays) EUB0000102c BRD4 | B | 6.1 | pIC50 | 790 | nM | IC50 | Affinity Biochemical Literature for EUbOPEN Chemogenomic Library |
| ChEMBL | Inhibition of BRD4 (unknown origin) by fluorescence anisotropy ligand displacement assay | B | 6.1 | pIC50 | 790 | nM | IC50 | Bioorg Med Chem Lett (2017) 27: 4051-4055 [PMID:28765013] |
| ChEMBL | Inhibition of BDR4- BD2 (unknown origin) by TR-FRET assay | B | 6.5 | pIC50 | 316.23 | nM | IC50 | Eur J Med Chem (2021) 226: 113853-113853 [PMID:34547507] |
| ChEMBL | Displacement of Alexa Fluor 647 labelled I-BET762 from N-terminal His6-tagged human BRD4 BD2 (1 to 477 residues)/BD1 Y97A mutant expressed in Escherichia coli after 1 hr by TR-FRET assay | B | 6.5 | pIC50 | 316.23 | nM | IC50 | J Med Chem (2020) 63: 9020-9044 [PMID:32787145] |
| ChEMBL | Inhibition of BRD4 BD2 (unknown origin) by TR-FRET assay | B | 6.5 | pIC50 | 316.23 | nM | IC50 | ACS Med Chem Lett (2023) 14: 1231-1236 [PMID:37736196] |
| ChEMBL | Displacement of Alexa Fluor 647 labelled ligand from His6-tagged BRD4 BD2 (1 to 477 residues)/BD1 Y97A mutant (unknown origin) after 30 mins by TR-FRET assay | B | 6.56 | pIC50 | 274 | nM | IC50 | J Med Chem (2020) 63: 9045-9069 [PMID:32691589] |
| ChEMBL | Inhibition of FAM-labeled ZBA248 binding to recombinant human N-terminal His6-tagged BRD4 bromodomain 2 (333 to 460 residues) expressed in Rosetta2 DE3 cells after 30 mins by Flourescence polarization assay | B | 6.65 | pIC50 | 226 | nM | IC50 | J Med Chem (2017) 60: 3887-3901 [PMID:28463487] |
| ChEMBL | Displacement of FAM-labeled ZBA248 from BRD4 BD2 (333 to 460 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells after 30 mins by fluorescence polarization assay | B | 6.65 | pIC50 | 226 | nM | IC50 | J Med Chem (2015) 58: 4927-4939 [PMID:26080064] |
| ChEMBL | Inhibition of BRD4 in human PBMC assessed as reduction in LPS-induced IL-6 secretion incubated for 18 to 24 hrs by MSD assay | B | 6.7 | pIC50 | 199.53 | nM | IC50 | J Med Chem (2021) 64: 12200-12227 [PMID:34387088] |
| ChEMBL | Affinity Phenotypic Cellular interaction: (Inhibition of MLL-fusion leukemic RS4:11 cells) EUB0000102c BRD4 | F | 6.72 | pIC50 | 192 | nM | IC50 | Affinity Phenotypic Cellular Literature for EUbOPEN Chemogenomic Library |
| ChEMBL | Affinity Phenotypic Cellular interaction: (Meso-scale discovery human IL6 assay (cytokine production in LPS stimulated PBMC cells)) EUB0000102c BRD4 | F | 6.8 | pIC50 | 160 | nM | IC50 | Affinity Phenotypic Cellular Literature for EUbOPEN Chemogenomic Library |
| ChEMBL | Inhibition of BRD4 in human Raji cells assessed as reduction of MYC expression after 4 hrs | B | 6.89 | pIC50 | 130 | nM | IC50 | ACS Med Chem Lett (2013) 4: 835-840 [PMID:24900758] |
| ChEMBL | Inhibition of histone binding to BRD4 (unknown origin) expressed in HEK293 cells using histone H3.3 as substrate incubated for 18 to 24 hrs by nano-BRET analysis | B | 6.9 | pIC50 | 125.89 | nM | IC50 | ACS Med Chem Lett (2023) 14: 1231-1236 [PMID:37736196] |
| ChEMBL | Affinity Phenotypic Cellular interaction: (Inhibition of MLL-fusion leukemic MOLM13 cells) EUB0000102c BRD4 | F | 6.92 | pIC50 | 120 | nM | IC50 | Affinity Phenotypic Cellular Literature for EUbOPEN Chemogenomic Library |
| ChEMBL | Inhibition of full length BRD4 (unknown origin) transfected in HEK293 cells incubated for 20 hrs measured by NanoBRET BRD4/Histone H3.3 interaction assay kit | B | 6.94 | pIC50 | 114.2 | nM | IC50 | Eur J Med Chem (2022) 239: 114519-114519 [PMID:35714446] |
| ChEMBL | Inhibition of BRD4 bromodomain-1 (unknown origin) by europium based LANCE TR-FRET assay | B | 6.97 | pIC50 | 107 | nM | IC50 | Bioorg Med Chem (2015) 23: 953-959 [PMID:25678016] |
| ChEMBL | Selectivity interaction (BET inhibitor selectivity panel (HumanTR-FRET peptide assay)) EUB0000102c BRD4 | B | 7 | pIC50 | 100 | nM | IC50 | Selectivity Literature for EUbOPEN Chemogenomic Library |
| ChEMBL | Inhibition of BRD4(1) (unknown origin) incubated for 4 hrs by (+)-JQ1 fluorescent ligand based fluorescence anisotrophy | B | 7 | pIC50 | 100 | nM | IC50 | J Med Chem (2015) 58: 1281-1297 [PMID:25559428] |
| ChEMBL | Displacement of Alexa Fluor 647 labelled ligand from His6-thr-tagged BRD4 BD1 (1 to 477 residues)/BD2 Y390A mutant (unknown origin) after 30 mins by TR-FRET assay | B | 7.44 | pIC50 | 36 | nM | IC50 | J Med Chem (2020) 63: 9045-9069 [PMID:32691589] |
| ChEMBL | Displacement of FAM-labeled ZBA248 from BRD4 BD1 (44 to 168 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells after 30 mins by fluorescence polarization assay | B | 7.5 | pIC50 | 31.7 | nM | IC50 | J Med Chem (2015) 58: 4927-4939 [PMID:26080064] |
| ChEMBL | Inhibition of FAM-labeled ZBA248 binding to recombinant human N-terminal His6-tagged BRD4 bromodomain 1 (44 to 168 residues) expressed in Rosetta2 DE3 cells after 30 mins by Flourescence polarization assay | B | 7.5 | pIC50 | 31.7 | nM | IC50 | J Med Chem (2017) 60: 3887-3901 [PMID:28463487] |
| ChEMBL | Affinity Phenotypic Cellular interaction: (Inhibition of MLL-fusion leukemic MV4:11 cells) EUB0000102c BRD4 | F | 7.59 | pIC50 | 26 | nM | IC50 | Affinity Phenotypic Cellular Literature for EUbOPEN Chemogenomic Library |
| ChEMBL | Displacement of Alexa Fluor 647 labelled ligand from recombinant human N-terminal 6His-tagged BRD4-BD1 Y390A mutant (1 to 477 residue) expressed in Escherichia coli incubated for 30 mins by TR-FRET assay | B | 7.6 | pIC50 | 25.12 | nM | IC50 | J Med Chem (2021) 64: 12200-12227 [PMID:34387088] |
| ChEMBL | Inhibition of BRD4 BD1 (unknown origin) by TR-FRET assay | B | 7.6 | pIC50 | 25.12 | nM | IC50 | ACS Med Chem Lett (2023) 14: 1231-1236 [PMID:37736196] |
| ChEMBL | Inhibition of BDR4-BD1 (unknown origin) by TR-FRET assay | B | 7.6 | pIC50 | 25.12 | nM | IC50 | Eur J Med Chem (2021) 226: 113853-113853 [PMID:34547507] |
| ChEMBL | Displacement of Alexa Fluor 647 labelled I-BET762 from N-terminal His6-tagged human BRD4 BD1 (1 to 477 residues)/BD2 Y390A mutant expressed in Escherichia coli after 1 hr by TR-FRET assay | B | 7.6 | pIC50 | 25.12 | nM | IC50 | J Med Chem (2020) 63: 9020-9044 [PMID:32787145] |
| ChEMBL | Displacement of Biotin-tagged [Lys(5,8,12,16)Ac]H4(1 to 21) peptide from GST-tagged BRD4-BD1 (unknown origin) incubated for 3 hrs by HTRF based TR-FRET assay | B | 7.6 | pIC50 | 25 | nM | IC50 | Bioorg Med Chem (2023) 93: 117461-117461 [PMID:37659219] |
| ChEMBL | Inhibition of His/FLAG-tagged BRD4 BD1 (unknown origin) using histone H4-TetraAcetylated-biotin peptide as substrate incubated for 20 mins by AlphaLISA assay | B | 7.74 | pIC50 | 18 | nM | IC50 | ACS Med Chem Lett (2016) 7: 145-150 [PMID:26985289] |
| ChEMBL | Inhibition of BRD4 bromodomain 1 (unknown origin) | B | 7.74 | pIC50 | 18 | nM | IC50 | J Med Chem (2016) 59: 1271-1298 [PMID:26572217] |
| ChEMBL | Inhibition of His-FLAG-tagged BRD4 binding domain1 (unknown origin) binding to H4-TetraAc-biotin peptide after 20 mins by AlphaLISA | B | 7.74 | pIC50 | 18 | nM | IC50 | ACS Med Chem Lett (2013) 4: 835-840 [PMID:24900758] |
| ChEMBL | Affinity Phenotypic Cellular interaction: (Inhibition of MLL-fusion leukemic NOMO1 cells) EUB0000102c BRD4 | F | 7.82 | pIC50 | 15 | nM | IC50 | Affinity Phenotypic Cellular Literature for EUbOPEN Chemogenomic Library |
| ChEMBL | Inhibition of halo-tagged BRD4 (unknown origin) expressed in HEK293 cells incubated for 4 hrs by biosensor assay | B | 5 | pEC50 | >10000 | nM | EC50 | ACS Med Chem Lett (2023) 14: 1231-1236 [PMID:37736196] |
| bromodomain testis associated/Bromodomain testis-specific protein in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1795185] [GtoPdb: 2729] [UniProtKB: Q58F21] | ||||||||
| ChEMBL | Affinity Phenotypic Cellular interaction: (Inhibition of MLL-fusion leukemic K562 cells) EUB0000102c BRDT | F | 4 | pIC50 | >100000 | nM | IC50 | Affinity Phenotypic Cellular Literature for EUbOPEN Chemogenomic Library |
| ChEMBL | Affinity Phenotypic Cellular interaction: (Inhibition of MLL-fusion leukemic MEG01 cells) EUB0000102c BRDT | F | 4.6 | pIC50 | 25000 | nM | IC50 | Affinity Phenotypic Cellular Literature for EUbOPEN Chemogenomic Library |
| ChEMBL | Displacement of Alexa Fluor 647 labelled I-BET762 from N-terminal His6-tagged human BRDT BD2 (1 to 397 residues)/BD1 Y66A mutant expressed in Escherichia coli after 1 hr by TR-FRET assay | B | 5.8 | pIC50 | 1584.89 | nM | IC50 | J Med Chem (2020) 63: 9020-9044 [PMID:32787145] |
| ChEMBL | Affinity Phenotypic Cellular interaction: (Meso-scale discovery human IL6 assay (cytokine production in LPS stimmulated human WB)) EUB0000102c BRDT | F | 5.9 | pIC50 | 1260 | nM | IC50 | Affinity Phenotypic Cellular Literature for EUbOPEN Chemogenomic Library |
| ChEMBL | Affinity Phenotypic Cellular interaction: (Meso-scale discovery human IL6 assay (cytokine production in LPS stimulated human WB)) EUB0000102c BRDT | F | 5.9 | pIC50 | 1260 | nM | IC50 | Affinity Phenotypic Cellular Literature for EUbOPEN Chemogenomic Library |
| ChEMBL | Affinity Phenotypic Cellular interaction: (Inhibition of MLL-fusion leukemic HEL cells) EUB0000102c BRDT | F | 6 | pIC50 | 1000 | nM | IC50 | Affinity Phenotypic Cellular Literature for EUbOPEN Chemogenomic Library |
| ChEMBL | Affinity Phenotypic Cellular interaction: (Inhibition of MLL-fusion leukemic HL60 cells) EUB0000102c BRDT | F | 6.05 | pIC50 | 890 | nM | IC50 | Affinity Phenotypic Cellular Literature for EUbOPEN Chemogenomic Library |
| ChEMBL | Affinity Phenotypic Cellular interaction: (Inhibition of MLL-fusion leukemic RS4:11 cells) EUB0000102c BRDT | F | 6.72 | pIC50 | 192 | nM | IC50 | Affinity Phenotypic Cellular Literature for EUbOPEN Chemogenomic Library |
| ChEMBL | Affinity Phenotypic Cellular interaction: (Meso-scale discovery human IL6 assay (cytokine production in LPS stimulated PBMC cells)) EUB0000102c BRDT | F | 6.8 | pIC50 | 160 | nM | IC50 | Affinity Phenotypic Cellular Literature for EUbOPEN Chemogenomic Library |
| ChEMBL | Displacement of Alexa Fluor 647 labelled I-BET762 from N-terminal His6-tagged human BRDT BD1 (1 to 397 residues)/BD2 Y309A mutant expressed in Escherichia coli after 1 hr by TR-FRET assay | B | 6.9 | pIC50 | 125.89 | nM | IC50 | J Med Chem (2020) 63: 9020-9044 [PMID:32787145] |
| ChEMBL | Affinity Phenotypic Cellular interaction: (Inhibition of MLL-fusion leukemic MOLM13 cells) EUB0000102c BRDT | F | 6.92 | pIC50 | 120 | nM | IC50 | Affinity Phenotypic Cellular Literature for EUbOPEN Chemogenomic Library |
| ChEMBL | Affinity Phenotypic Cellular interaction: (Inhibition of MLL-fusion leukemic MV4:11 cells) EUB0000102c BRDT | F | 7.59 | pIC50 | 26 | nM | IC50 | Affinity Phenotypic Cellular Literature for EUbOPEN Chemogenomic Library |
| ChEMBL | Affinity Phenotypic Cellular interaction: (Inhibition of MLL-fusion leukemic NOMO1 cells) EUB0000102c BRDT | F | 7.82 | pIC50 | 15 | nM | IC50 | Affinity Phenotypic Cellular Literature for EUbOPEN Chemogenomic Library |
| C-C motif chemokine 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1649052] [UniProtKB: P13500] | ||||||||
| ChEMBL | Inhibition of MCP-1 in LPS-stimulated human whole blood pretreated with compound for 30 mins followed by LPS-stimulation and measured after 10 mins by microplate analysis | B | 6.7 | pIC50 | 199.53 | nM | IC50 | ACS Med Chem Lett (2023) 14: 1231-1236 [PMID:37736196] |
| ChEMBL | Inhibition of MCP-1 in LPS-stimulated human PBMC cells pretreated with compound for 30 mins followed by LPS-stimulation and measured after 10 mins by microplate analysis | B | 7.4 | pIC50 | 39.81 | nM | IC50 | ACS Med Chem Lett (2023) 14: 1231-1236 [PMID:37736196] |
| CREB binding protein/CREB-binding protein in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5747] [GtoPdb: 2734] [UniProtKB: Q92793] | ||||||||
| ChEMBL | Binding affinity to biotinylated CREBBP (1043 to 1159 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells by bio-layer interferometry method | B | 5.51 | pKd | 3084 | nM | Kd | J Med Chem (2015) 58: 4927-4939 [PMID:26080064] |
| COX-2 /Cyclooxygenase-2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL230] [GtoPdb: 1376] [UniProtKB: P35354] | ||||||||
| ChEMBL | Selectivity interaction (BET inhibitor selectivity panel (Human inhibition FLINT assay)) EUB0000102c PTGS2 | B | 4 | pIC50 | >100000 | nM | IC50 | Selectivity Literature for EUbOPEN Chemogenomic Library |
| CYP2C9/Cytochrome P450 2C9 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3397] [GtoPdb: 1326] [UniProtKB: P11712] | ||||||||
| ChEMBL | Selectivity interaction (BET inhibitor selectivity panel (Human inhibition FLINT assay)) EUB0000102c CYP2C9 | B | 5.38 | pIC50 | 4170 | nM | IC50 | Selectivity Literature for EUbOPEN Chemogenomic Library |
| CYP2D6/Cytochrome P450 2D6 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL289] [GtoPdb: 1329] [UniProtKB: P10635] | ||||||||
| ChEMBL | Selectivity interaction (BET inhibitor selectivity panel (Human inhibition FLINT assay)) EUB0000102c CYP2D6 | B | 4.42 | pIC50 | 38020 | nM | IC50 | Selectivity Literature for EUbOPEN Chemogenomic Library |
| CYP3A4/Cytochrome P450 3A4 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL340] [GtoPdb: 1337] [UniProtKB: P08684] | ||||||||
| ChEMBL | Selectivity interaction (BET inhibitor selectivity panel (Human Vivid Red assay)) EUB0000102c CYP3A4 | B | 4.32 | pIC50 | 47860 | nM | IC50 | Selectivity Literature for EUbOPEN Chemogenomic Library |
| ChEMBL | Selectivity interaction (BET inhibitor selectivity panel (Human Vivid Green assay)) EUB0000102c CYP3A4 | B | 4.86 | pIC50 | 13800 | nM | IC50 | Selectivity Literature for EUbOPEN Chemogenomic Library |
| D1 receptor/Dopamine D1 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2056] [GtoPdb: 214] [UniProtKB: P21728] | ||||||||
| ChEMBL | Selectivity interaction (BET inhibitor selectivity panel (Human antagonist TR-FRET assay)) EUB0000102c DRD1 | B | 4.5 | pIC50 | >31600 | nM | IC50 | Selectivity Literature for EUbOPEN Chemogenomic Library |
| D2 receptor/Dopamine D2 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL217] [GtoPdb: 215] [UniProtKB: P14416] | ||||||||
| ChEMBL | Selectivity interaction (BET inhibitor selectivity panel (Human antagonist GTPgS assay)) EUB0000102c DRD2 | B | 4 | pIC50 | >100000 | nM | IC50 | Selectivity Literature for EUbOPEN Chemogenomic Library |
| DAT/Dopamine transporter in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL238] [GtoPdb: 927] [UniProtKB: Q01959] | ||||||||
| ChEMBL | Selectivity interaction (BET inhibitor selectivity panel (Human SPA binding assay)) EUB0000102c SLC6A3 | B | 4 | pIC50 | >100000 | nM | IC50 | Selectivity Literature for EUbOPEN Chemogenomic Library |
| glycogen synthase kinase 3 beta/Glycogen synthase kinase-3 beta in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL262] [GtoPdb: 2030] [UniProtKB: P49841] | ||||||||
| ChEMBL | Selectivity interaction (BET inhibitor selectivity panel (Human FP binding assay)) EUB0000102c GSK3B | B | 4.6 | pIC50 | >25000 | nM | IC50 | Selectivity Literature for EUbOPEN Chemogenomic Library |
| Kv11.1/HERG in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL240] [GtoPdb: 572] [UniProtKB: Q12809] | ||||||||
| ChEMBL | Selectivity interaction (BET inhibitor selectivity panel (Human blocker PatchXpress assay)) EUB0000102c KCNH2 | B | 5 | pIC50 | 10000 | nM | IC50 | Selectivity Literature for EUbOPEN Chemogenomic Library |
| H1 receptor/Histamine H1 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL231] [GtoPdb: 262] [UniProtKB: P35367] | ||||||||
| ChEMBL | Selectivity interaction (BET inhibitor selectivity panel (Human antagonist intracellular Ca2+ luminescence assay)) EUB0000102c HRH1 | B | 4.5 | pIC50 | >31600 | nM | IC50 | Selectivity Literature for EUbOPEN Chemogenomic Library |
| κ receptor/Kappa opioid receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL237] [GtoPdb: 318] [UniProtKB: P41145] | ||||||||
| ChEMBL | Selectivity interaction (BET inhibitor selectivity panel (Human antagonist GTPgS assay)) EUB0000102c OPRK1 | B | 4 | pIC50 | >100000 | nM | IC50 | Selectivity Literature for EUbOPEN Chemogenomic Library |
| Monoamine oxidase B in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2039] [GtoPdb: 2490] [UniProtKB: P27338] | ||||||||
| ChEMBL | Selectivity interaction (BET inhibitor selectivity panel (Human inhibition FLINT assay)) EUB0000102c MAOB | B | 4.3 | pIC50 | 50000 | nM | IC50 | Selectivity Literature for EUbOPEN Chemogenomic Library |
| μ receptor/Mu opioid receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL233] [GtoPdb: 319] [UniProtKB: P35372] | ||||||||
| ChEMBL | Selectivity interaction (BET inhibitor selectivity panel (Human antagonist GTPgS assay)) EUB0000102c OPRM1 | B | 4 | pIC50 | >100000 | nM | IC50 | Selectivity Literature for EUbOPEN Chemogenomic Library |
| M1 receptor/Muscarinic acetylcholine receptor M1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL216] [GtoPdb: 13] [UniProtKB: P11229] | ||||||||
| ChEMBL | Selectivity interaction (BET inhibitor selectivity panel (Human antagonist intracellular Ca2+ fluorescence assay)) EUB0000102c CHRM1 | B | 4.8 | pIC50 | >15800 | nM | IC50 | Selectivity Literature for EUbOPEN Chemogenomic Library |
| M2 receptor/Muscarinic acetylcholine receptor M2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL211] [GtoPdb: 14] [UniProtKB: P08172] | ||||||||
| ChEMBL | Selectivity interaction (BET inhibitor selectivity panel (Human antagonist intracellular Ca2+ fluorescence assay)) EUB0000102c CHRM2 | B | 4.8 | pIC50 | >15800 | nM | IC50 | Selectivity Literature for EUbOPEN Chemogenomic Library |
| NK1 receptor/Neurokinin 1 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL249] [GtoPdb: 360] [UniProtKB: P25103] | ||||||||
| ChEMBL | Selectivity interaction (BET inhibitor selectivity panel (Human antagonist intracellular Ca2+ luminescence assay)) EUB0000102c TACR1 | B | 4.9 | pIC50 | 12600 | nM | IC50 | Selectivity Literature for EUbOPEN Chemogenomic Library |
| NET/Norepinephrine transporter in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL222] [GtoPdb: 926] [UniProtKB: P23975] | ||||||||
| ChEMBL | Selectivity interaction (BET inhibitor selectivity panel (Human SPA binding assay)) EUB0000102c SLC6A2 | B | 4 | pIC50 | >100000 | nM | IC50 | Selectivity Literature for EUbOPEN Chemogenomic Library |
| phosphodiesterase 4B/Phosphodiesterase 4B in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL275] [GtoPdb: 1301] [UniProtKB: Q07343] | ||||||||
| ChEMBL | Inhibition of PDE4B | B | 5.4 | pIC50 | 3981.07 | nM | IC50 | Bioorg Med Chem Lett (2012) 22: 2968-2972 [PMID:22437115] |
| ChEMBL | Selectivity interaction (BET inhibitor selectivity panel (Human inhibition luminescence assay)) EUB0000102c PDE4B | B | 5.44 | pIC50 | 3630 | nM | IC50 | Selectivity Literature for EUbOPEN Chemogenomic Library |
| phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma/PI3-kinase p110-gamma subunit in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3267] [GtoPdb: 2156] [UniProtKB: P48736] | ||||||||
| ChEMBL | Selectivity interaction (BET inhibitor selectivity panel (Human antagonist TR-FRET assay)) EUB0000102c PIK3CG | B | 4.6 | pIC50 | >25000 | nM | IC50 | Selectivity Literature for EUbOPEN Chemogenomic Library |
| Kv12.2/Potassium voltage-gated channel subfamily H member 3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2363017] [GtoPdb: 576] [UniProtKB: Q9ULD8] | ||||||||
| ChEMBL | Selectivity interaction (BET inhibitor selectivity panel (Human FP binding assay)) EUB0000102c KCNH3 | B | 4.4 | pIC50 | 40000 | nM | IC50 | Selectivity Literature for EUbOPEN Chemogenomic Library |
| aurora kinase B/Serine/threonine-protein kinase Aurora-B in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2185] [GtoPdb: 1937] [UniProtKB: Q96GD4] | ||||||||
| ChEMBL | Selectivity interaction (BET inhibitor selectivity panel (Human inhibition FP binding assay)) EUB0000102c AURKB | B | 4.6 | pIC50 | >25000 | nM | IC50 | Selectivity Literature for EUbOPEN Chemogenomic Library |
| 5-HT1A receptor/Serotonin 1a (5-HT1a) receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL214] [GtoPdb: 1] [UniProtKB: P08908] | ||||||||
| ChEMBL | Selectivity interaction (BET inhibitor selectivity panel (Human SPA binding assay)) EUB0000102c HTR1A | B | 4 | pIC50 | >100000 | nM | IC50 | Selectivity Literature for EUbOPEN Chemogenomic Library |
| 5-HT1B receptor/Serotonin 1b (5-HT1b) receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1898] [GtoPdb: 2] [UniProtKB: P28222] | ||||||||
| ChEMBL | Selectivity interaction (BET inhibitor selectivity panel (Human antagonist GTPgS assay)) EUB0000102c HTR1B | B | 4 | pIC50 | >100000 | nM | IC50 | Selectivity Literature for EUbOPEN Chemogenomic Library |
| 5-HT2A receptor/Serotonin 2a (5-HT2a) receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL224] [GtoPdb: 6] [UniProtKB: P28223] | ||||||||
| ChEMBL | Selectivity interaction (BET inhibitor selectivity panel (Human antagonist intracellular Ca2+ luminescence assay)) EUB0000102c HTR2A | B | 4.4 | pIC50 | >40000 | nM | IC50 | Selectivity Literature for EUbOPEN Chemogenomic Library |
| 5-HT2C receptor/Serotonin 2c (5-HT2c) receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL225] [GtoPdb: 8] [UniProtKB: P28335] | ||||||||
| ChEMBL | Selectivity interaction (BET inhibitor selectivity panel (Human antagonist intracellular Ca2+ luminescence assay)) EUB0000102c HTR2C | B | 4.4 | pIC50 | >40000 | nM | IC50 | Selectivity Literature for EUbOPEN Chemogenomic Library |
| 5-HT3A/Serotonin 3a (5-HT3a) receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1899] [GtoPdb: 373] [UniProtKB: P46098] | ||||||||
| ChEMBL | Selectivity interaction (BET inhibitor selectivity panel (Human antagonist intracellular Ca2+ fluorescence assay)) EUB0000102c HTR3A | B | 4.3 | pIC50 | >50000 | nM | IC50 | Selectivity Literature for EUbOPEN Chemogenomic Library |
| Nav1.5/Sodium channel protein type V alpha subunit in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1980] [GtoPdb: 582] [UniProtKB: Q14524] | ||||||||
| ChEMBL | Selectivity interaction (BET inhibitor selectivity panel (Human Blocker ionworks assay)) EUB0000102c SCN5A | B | 4.1 | pIC50 | 79400 | nM | IC50 | Selectivity Literature for EUbOPEN Chemogenomic Library |
| OATP1B1/Solute carrier organic anion transporter family member 1B1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1697668] [GtoPdb: 1220] [UniProtKB: Q9Y6L6] | ||||||||
| ChEMBL | Selectivity interaction (BET inhibitor selectivity panel (Human inhibition FLINT imaging assay)) EUB0000102c SLCO1B1 | B | 4.9 | pIC50 | 12600 | nM | IC50 | Selectivity Literature for EUbOPEN Chemogenomic Library |
| LCK proto-oncogene, Src family tyrosine kinase/Tyrosine-protein kinase LCK in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL258] [GtoPdb: 2053] [UniProtKB: P06239] | ||||||||
| ChEMBL | Selectivity interaction (BET inhibitor selectivity panel (Human inhibition FP binding assay)) EUB0000102c LCK | B | 4.6 | pIC50 | >25000 | nM | IC50 | Selectivity Literature for EUbOPEN Chemogenomic Library |
| V1A receptor/Vasopressin V1a receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1889] [GtoPdb: 366] [UniProtKB: P37288] | ||||||||
| ChEMBL | Selectivity interaction (BET inhibitor selectivity panel (Human antagonist intracellular Ca2+ fluorescence assay)) EUB0000102c AVPR1A | B | 4.5 | pIC50 | 31600 | nM | IC50 | Selectivity Literature for EUbOPEN Chemogenomic Library |
| Cav1.2/Voltage-gated L-type calcium channel alpha-1C subunit in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1940] [GtoPdb: 529] [UniProtKB: Q13936] | ||||||||
| ChEMBL | Selectivity interaction (BET inhibitor selectivity panel (Human blocker intracellular Ca2+ fluorescence assay)) EUB0000102c CACNA1C | B | 4.8 | pIC50 | >15800 | nM | IC50 | Selectivity Literature for EUbOPEN Chemogenomic Library |
| Voltage-gated potassium channel beta subunit Mink in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4872] [UniProtKB: P15382] | ||||||||
| ChEMBL | Selectivity interaction (BET inhibitor selectivity panel (Human Blocker ionworks assay)) EUB0000102c KCNE1 | B | 4.6 | pIC50 | >25000 | nM | IC50 | Selectivity Literature for EUbOPEN Chemogenomic Library |
| Kv1.5/Voltage-gated potassium channel subunit Kv1.5 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4306] [GtoPdb: 542] [UniProtKB: P22460] | ||||||||
| ChEMBL | Selectivity interaction (BET inhibitor selectivity panel (Human Blocker ionworks assay)) EUB0000102c KCNA5 | B | 4.8 | pIC50 | 15800 | nM | IC50 | Selectivity Literature for EUbOPEN Chemogenomic Library |
| Kv7.1/Voltage-gated potassium channel subunit Kv7.1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1866] [GtoPdb: 560] [UniProtKB: P51787] | ||||||||
| ChEMBL | Selectivity interaction (BET inhibitor selectivity panel (Human Blocker ionworks assay)) EUB0000102c KCNQ1 | B | 4.6 | pIC50 | >25000 | nM | IC50 | Selectivity Literature for EUbOPEN Chemogenomic Library |
| Cav2.1/Voltage-gated P/Q-type calcium channel alpha-1A subunit in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4266] [GtoPdb: 532] [UniProtKB: O00555] | ||||||||
| ChEMBL | Selectivity interaction (BET inhibitor selectivity panel (Human blocker intracellular Ca2+ fluorescence assay)) EUB0000102c CACNA1A | B | 5.9 | pIC50 | 1260 | nM | IC50 | Selectivity Literature for EUbOPEN Chemogenomic Library |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]
